plowe68
Mechanical
- Jul 14, 2015
- 3
We are a medical device manufacturer since the 70's. With people coming and going our drawings and BOM structure has evolved into two different groups. Group 1 drawings (traditional) for example would be of a molded component that would specify the material in the notes. Group 2 drawings (new) for example would be of a molded component that would include a BOM, where the BOM would have the material as an item. That material item would be its own drawing and in that drawing we would specify the material details.
All other ancillary groups here are capable of dealing with these two groups.
Is there a direction the med device industry is going where group 1 or group 2 would be better suited?
Any focus by FDA on this subject? Or other auditing bodies that would be a red flag to them?
I didn't find a drafting requirement that specifies how BOM's are to be structured. Does one exist?
any feedback is greatly appreciated.
All other ancillary groups here are capable of dealing with these two groups.
Is there a direction the med device industry is going where group 1 or group 2 would be better suited?
Any focus by FDA on this subject? Or other auditing bodies that would be a red flag to them?
I didn't find a drafting requirement that specifies how BOM's are to be structured. Does one exist?
any feedback is greatly appreciated.